COMMUNIQUÉS West-GlobeNewswire
-
NADP: provider, patient benefits rose; dental plan enrollment fell in 2024
18/05/2026 -
Disclosure of transparency notifications from BlackRock, Inc.
18/05/2026 -
Letter to Shareholders from CEO Dr. Ryan Saadi
18/05/2026 -
Ipsen - Avril 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
18/05/2026 -
Carbios announces a change in its governance and the appointment of Benoît Grenot as Chief Executive Officer
18/05/2026 -
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
18/05/2026 -
Carbios annonce une évolution de sa gouvernance et la nomination de Benoît Grenot en qualité de Directeur Général.
18/05/2026 -
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
18/05/2026 -
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs
18/05/2026 -
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION
18/05/2026 -
Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option
18/05/2026 -
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
18/05/2026 -
Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End
18/05/2026 -
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
18/05/2026 -
Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development
18/05/2026 -
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
18/05/2026 -
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
18/05/2026 -
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
18/05/2026 -
Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
18/05/2026
Pages